|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, H:
E.C.3.4.21.5
- thrombin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
226:1085-1099
(1992)
|
|
PubMed id:
|
|
|
|
|
| |
|
Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
|
|
H.Brandstetter,
D.Turk,
H.W.Hoeffken,
D.Grosse,
J.Stürzebecher,
P.D.Martin,
B.F.Edwards,
W.Bode.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Well-diffracting crystals of bovine epsilon-thrombin in complex with several
"non-peptidic" benzamidine and arginine-based thrombin inhibitors have
been obtained by co-crystallization. The 2.3 A crystal structures of three
complexes formed either with NAPAP, 4-TAPAP, or MQPA, were solved by Patterson
search methods and refined to crystallographic R-values of 0.167 to 0.178. The
active-site environment of thrombin is only slightly affected by binding of the
different inhibitors; in particular, the exposed "60-insertion loop"
essentially maintains its typical projecting structure. The D-stereoisomer of
NAPAP and the L-stereoisomer of MQPA bind to thrombin with very similar
conformations, as previously inferred from their binding to bovine trypsin; the
arginine side-chain of the latter inserts into the specificity pocket in a
"non-canonical" manner. The L-stereoisomer of 4-TAPAP, whose binding
geometry towards trypsin was only poorly defined, is bound to the thrombin
active-site in a compact conformation. In contrast to NAPAP, the distal
p-amidino/guanidino groups of 4-TAPAP and MQPA do not interact with the
carboxylate group of Asp189 in the thrombin specificity pocket in a
"symmetrical" twin N-twin O manner, but through "lateral"
single N-twin O contacts; in contrast to the p-amidino group of 4-TAPAP,
however, the guanidyl group of MQPA packs favourably in the pocket due to an
elaborate hydrogen bond network, which includes two entrapped water molecules.
These thrombin structures confirm previous conclusions of the important role of
the intermolecular hydrogen bonds formed with Gly216, and of the good sterical
fit of the terminal bulky hydrophobic inhibitor groups with the hydrophobic aryl
binding site and the S2-cavity, respectively, for tight thrombin active site
binding of these non-peptidic inhibitors. These accurate crystal structures are
presumed to be excellent starting points for the design and the elaboration of
improved antithrombotics.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Chemical ormulas of NAPAP (with residues XasIl. GlypI2, Papal3 and Pipn14): (~cr-(2-napthyl-s~Ilphotl~l-
|
 |
Figure 4.
Figure 4. ctive site region f the complex formed between NAPAP (thick lines) and bovine thrombin (thin lines)
superimposed with the final 2F,,, -Fcslf electron denity. The view is (similar to Figs 2 and 3) towards the thrombin
surface; the active site residues are o the ight, the specificity pocket is in the back. Contou surface is at @9a.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1992,
226,
1085-1099)
copyright 1992.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
O.Nicolotti,
I.Giangreco,
T.F.Miscioscia,
M.Convertino,
F.Leonetti,
L.Pisani,
and
A.Carotti
(2010).
Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model.
|
| |
J Comput Aided Mol Des,
24,
117-129.
|
 |
|
|
|
|
 |
H.Li,
H.Zhang,
M.Zheng,
J.Luo,
L.Kang,
X.Liu,
X.Wang,
and
H.Jiang
(2009).
An effective docking strategy for virtual screening based on multi-objective optimization algorithm.
|
| |
BMC Bioinformatics,
10,
58.
|
 |
|
|
|
|
 |
L.D.Hicks,
J.L.Hyatt,
S.Stoddard,
L.Tsurkan,
C.C.Edwards,
R.M.Wadkins,
and
P.M.Potter
(2009).
Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.
|
| |
J Med Chem,
52,
3742-3752.
|
 |
|
|
|
|
 |
S.Macedo-Ribeiro,
C.Almeida,
B.M.Calisto,
T.Friedrich,
R.Mentele,
J.Stürzebecher,
P.Fuentes-Prior,
and
P.J.Pereira
(2008).
Isolation, cloning and structural characterisation of boophilin, a multifunctional Kunitz-type proteinase inhibitor from the cattle tick.
|
| |
PLoS ONE,
3,
e1624.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.A.Landrum,
J.E.Penzotti,
and
S.Putta
(2006).
Feature-map vectors: a new class of informative descriptors for computational drug discovery.
|
| |
J Comput Aided Mol Des,
20,
751-762.
|
 |
|
|
|
|
 |
R.Friedrich,
P.Panizzi,
S.Kawabata,
W.Bode,
P.E.Bock,
and
P.Fuentes-Prior
(2006).
Structural basis for reduced staphylocoagulase-mediated bovine prothrombin activation.
|
| |
J Biol Chem,
281,
1188-1195.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.M.Truhlar,
C.H.Croy,
J.W.Torpey,
J.R.Koeppe,
and
E.A.Komives
(2006).
Solvent accessibility of protein surfaces by amide H/2H exchange MALDI-TOF mass spectrometry.
|
| |
J Am Soc Mass Spectrom,
17,
1490-1497.
|
 |
|
|
|
|
 |
E.Toyota,
H.Sekizaki,
Y.U.Takahashi,
K.Itoh,
and
K.Tanizawa
(2005).
Amidino-containing Schiff base copper(II) and iron(III) chelates as a thrombin inhibitor.
|
| |
Chem Pharm Bull (Tokyo),
53,
22-26.
|
 |
|
|
|
|
 |
W.Bode
(2005).
The structure of thrombin, a chameleon-like proteinase.
|
| |
J Thromb Haemost,
3,
2379-2388.
|
 |
|
|
|
|
 |
E.S.Henriques,
N.Fonseca,
and
M.J.Ramos
(2004).
On the modeling of snake venom serine proteinase interactions with benzamidine-based thrombin inhibitors.
|
| |
Protein Sci,
13,
2355-2369.
|
 |
|
|
|
|
 |
J.A.Krauser,
J.Potempa,
J.Travis,
and
J.C.Powers
(2002).
Inhibition of arginine gingipains (RgpB and HRgpA) with benzamidine inhibitors: zinc increases inhibitory potency.
|
| |
Biol Chem,
383,
1193-1198.
|
 |
|
|
|
|
 |
M.M.Mueller,
S.Sperl,
J.Stürzebecher,
W.Bode,
and
L.Moroder
(2002).
(R)-3-Amidinophenylalanine-derived inhibitors of factor Xa with a novel active-site binding mode.
|
| |
Biol Chem,
383,
1185-1191.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.Kairys,
and
M.K.Gilson
(2002).
Enhanced docking with the mining minima optimizer: acceleration and side-chain flexibility.
|
| |
J Comput Chem,
23,
1656-1670.
|
 |
|
|
|
|
 |
S.Sperl,
A.Bergner,
J.Stürzebecher,
V.Magdolen,
W.Bode,
and
L.Moroder
(2000).
Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.
|
| |
Biol Chem,
381,
321-329.
|
 |
|
|
|
|
 |
S.Sperl,
U.Jacob,
N.Arroyo de Prada,
J.Stürzebecher,
O.G.Wilhelm,
W.Bode,
V.Magdolen,
R.Huber,
and
L.Moroder
(2000).
(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase.
|
| |
Proc Natl Acad Sci U S A,
97,
5113-5118.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Lombardi,
G.De Simone,
F.Nastri,
S.Galdiero,
R.Della Morte,
N.Staiano,
C.Pedone,
M.Bolognesi,
and
V.Pavone
(1999).
The crystal structure of alpha-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode.
|
| |
Protein Sci,
8,
91-95.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Lombardi,
G.De Simone,
S.Galdiero,
N.Staiano,
F.Nastri,
and
V.Pavone
(1999).
From natural to synthetic multisite thrombin inhibitors.
|
| |
Biopolymers,
51,
19-39.
|
 |
|
|
|
|
 |
I.Mochalkin,
and
A.Tulinsky
(1999).
Structures of thrombin retro-inhibited with SEL2711 and SEL2770 as they relate to factor Xa binding.
|
| |
Acta Crystallogr D Biol Crystallogr,
55,
785-793.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Scarsi,
N.Majeux,
and
A.Caflisch
(1999).
Hydrophobicity at the surface of proteins.
|
| |
Proteins,
37,
565-575.
|
 |
|
|
|
|
 |
N.Majeux,
M.Scarsi,
J.Apostolakis,
C.Ehrhardt,
and
A.Caflisch
(1999).
Exhaustive docking of molecular fragments with electrostatic solvation.
|
| |
Proteins,
37,
88.
|
 |
|
|
|
|
 |
R.M.Knegtel,
and
M.Wagener
(1999).
Efficacy and selectivity in flexible database docking.
|
| |
Proteins,
37,
334-345.
|
 |
|
|
|
|
 |
T.Steinmetzer,
M.Renatus,
S.Künzel,
A.Eichinger,
W.Bode,
P.Wikström,
J.Hauptmann,
and
J.Stürzebecher
(1999).
Design and evaluation of novel bivalent thrombin inhibitors based on amidinophenylalanines.
|
| |
Eur J Biochem,
265,
598-605.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.L.Strickland,
J.M.Fevig,
R.A.Galemmo,
B.L.Wells,
C.A.Kettner,
and
P.C.Weber
(1998).
Biochemical and crystallographic characterization of homologous non-peptidic thrombin inhibitors having alternate binding modes.
|
| |
Acta Crystallogr D Biol Crystallogr,
54,
1207-1215.
|
 |
|
|
|
|
 |
G.De Simone,
A.Lombardi,
S.Galdiero,
F.Nastri,
R.Della Morte,
N.Staiano,
C.Pedone,
M.Bolognesi,
and
V.Pavone
(1998).
Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.
|
| |
Protein Sci,
7,
243-253.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Kubinyi
(1998).
[Molecular similarity. 2. The structural basis of drug design]
|
| |
Pharm Unserer Zeit,
27,
158-172.
|
 |
|
|
|
|
 |
I.Massova,
P.Martin,
A.Bulychev,
R.Kocz,
M.Doyle,
B.F.Edwards,
and
S.Mobashery
(1998).
Templates for design of inhibitors for serine proteases: application of the program DOCK to the discovery of novel inhibitors for thrombin.
|
| |
Bioorg Med Chem Lett,
8,
2463-2466.
|
 |
|
|
|
|
 |
I.R.Weber,
R.Neidlein,
W.von der Saal,
F.Grams,
H.Leinert,
K.Strein,
R.A.Engh,
and
R.Kucznierz
(1998).
Diarylsulfonamides as selective, non-peptidic thrombin inhibitors.
|
| |
Bioorg Med Chem Lett,
8,
1613-1618.
|
 |
|
|
|
|
 |
K.Kamata,
H.Kawamoto,
T.Honma,
T.Iwama,
and
S.H.Kim
(1998).
Structural basis for chemical inhibition of human blood coagulation factor Xa.
|
| |
Proc Natl Acad Sci U S A,
95,
6630-6635.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Tada,
and
J.J.Blow
(1998).
The replication licensing system.
|
| |
Biol Chem,
379,
941-949.
|
 |
|
|
|
|
 |
J.J.Slon-Usakiewicz,
E.Purisima,
Y.Tsuda,
T.Sulea,
A.Pedyczak,
J.Féthière,
M.Cygler,
and
Y.Konishi
(1997).
Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker.
|
| |
Biochemistry,
36,
13494-13502.
|
 |
|
|
|
|
 |
M.G.Malkowski,
P.D.Martin,
J.C.Guzik,
and
B.F.Edwards
(1997).
The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro-Trp segment and active site residues upon ligand binding.
|
| |
Protein Sci,
6,
1438-1448.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Renatus,
W.Bode,
R.Huber,
J.Stürzebecher,
D.Prasa,
S.Fischer,
U.Kohnert,
and
M.T.Stubbs
(1997).
Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors.
|
| |
J Biol Chem,
272,
21713-21719.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Fuentes-Prior,
C.Noeske-Jungblut,
P.Donner,
W.D.Schleuning,
R.Huber,
and
W.Bode
(1997).
Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug.
|
| |
Proc Natl Acad Sci U S A,
94,
11845-11850.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.van de Locht,
M.T.Stubbs,
W.Bode,
T.Friedrich,
C.Bollschweiler,
W.Höffken,
and
R.Huber
(1996).
The ornithodorin-thrombin crystal structure, a key to the TAP enigma?
|
| |
EMBO J,
15,
6011-6017.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.A.Bertrand,
J.Oleksyszyn,
C.M.Kam,
B.Boduszek,
S.Presnell,
R.R.Plaskon,
F.L.Suddath,
J.C.Powers,
and
L.D.Williams
(1996).
Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.
|
| |
Biochemistry,
35,
3147-3155.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Féthière,
Y.Tsuda,
R.Coulombe,
Y.Konishi,
and
M.Cygler
(1996).
Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
|
| |
Protein Sci,
5,
1174-1183.
|
 |
|
|
|
|
 |
J.H.Matthews,
R.Krishnan,
M.J.Costanzo,
B.E.Maryanoff,
and
A.Tulinsky
(1996).
Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site.
|
| |
Biophys J,
71,
2830-2839.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.D.Boxrud,
and
L.J.Berliner
(1996).
Comparison of the active-site conformations of bovine alpha-thrombin and meizothrombin(desF1) by electron spin resonance.
|
| |
J Protein Chem,
15,
231-242.
|
 |
|
|
|
|
 |
P.D.Grootenhuis,
and
M.Karplus
(1996).
Functionality map analysis of the active site cleft of human thrombin.
|
| |
J Comput Aided Mol Des,
10,
1.
|
 |
|
|
|
|
 |
P.O.Freskgård,
O.H.Olsen,
and
E.Persson
(1996).
Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.
|
| |
Protein Sci,
5,
1531-1540.
|
 |
|
|
|
|
 |
R.A.Engh,
H.Brandstetter,
G.Sucher,
A.Eichinger,
U.Baumann,
W.Bode,
R.Huber,
T.Poll,
R.Rudolph,
and
W.von der Saal
(1996).
Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design.
|
| |
Structure,
4,
1353-1362.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.van de Locht,
D.Lamba,
M.Bauer,
R.Huber,
T.Friedrich,
B.Kröger,
W.Höffken,
and
W.Bode
(1995).
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin.
|
| |
EMBO J,
14,
5149-5157.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.E.Maryanoff,
H.C.Zhang,
M.N.Greco,
K.A.Glover,
J.A.Kauffman,
and
P.Andrade-Gordon
(1995).
Cyclotheonamide derivatives: synthesis and thrombin inhibition. Exploration of specific structure-function issues.
|
| |
Bioorg Med Chem,
3,
1025-1038.
|
 |
|
|
|
|
 |
F.Grams,
P.Reinemer,
J.C.Powers,
T.Kleine,
M.Pieper,
H.Tschesche,
R.Huber,
and
W.Bode
(1995).
X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
|
| |
Eur J Biochem,
228,
830-841.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Klebe,
T.Mietzner,
and
F.Weber
(1994).
Different approaches toward an automatic structural alignment of drug molecules: applications to sterol mimics, thrombin and thermolysin inhibitors.
|
| |
J Comput Aided Mol Des,
8,
751-778.
|
 |
|
|
|
|
 |
G.Klebe,
and
T.Mietzner
(1994).
A fast and efficient method to generate biologically relevant conformations.
|
| |
J Comput Aided Mol Des,
8,
583-606.
|
 |
|
|
|
|
 |
H.J.Böhm
(1994).
The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.
|
| |
J Comput Aided Mol Des,
8,
243-256.
|
 |
|
|
|
|
 |
H.Kubinyi
(1994).
[The key and the lock. I. The basis of drug action]
|
| |
Pharm Unserer Zeit,
23,
158-168.
|
 |
|
|
|
|
 |
U.Egner,
G.A.Hoyer,
and
W.D.Schleuning
(1994).
Rational design of hirulog-type inhibitors of thrombin.
|
| |
J Comput Aided Mol Des,
8,
479-490.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |